In-Person Access Only | 7.50 CE/CME Credits & MOC Points
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Total Health's 2025 ASCO Direct™ Washington D.C. Conference is an officially licensed ASCO Direct meeting. This Post ASCO Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Conference Agenda
Saturday, August 2, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Colorectal Cancer
Eric Christenson, MD | Johns Hopkins University
9:10 AM
Non-Colorectal Cancer
David Ilson, MD, PhD | Memorial Sloan Kettering Cancer Center
9:40 AM
Non-CME Breakfast - Incyte Jakafi - Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)
Amit Mehta, MD | Premier Hematology and Tele-Oncology Center, PLLC
9:55 AM
Non-CME Breakfast
10:40 AM
Prostate Cancer
Jeanny Aragon-Ching, MD | Inova Schar Cancer Institute
11:10 AM
Non-Prostate Cancer
Russell Pachynski, MD | Washington University School of Medicine
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Pfizer Breast - Treatment Considerations for Patients With HR+/HER2- mBC, Including Patients ≥65 Years of Age
Neil Iyengar, MD | Breast Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
12:40 PM
Housekeeping and Survey
12:50 PM
Leukemia
Tapan Kadia, MD | MD Anderson
1:20 PM
Lymphoma
Kieron Dunleavy, MD | MedStar Health
1:50 PM
Multiple Myeloma
Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center
2:20 PM
Melanoma
Geoffrey Gibney, MD | MedStar Health
2:50 PM
Networking Reception
3:50 PM
ADJOURN
Sunday, August 3, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:40 AM
Small Cell Lung Cancer
Chul Kim, MD, MPH | MedStar Health
9:10 AM
Non-Small Cell Lung Cancer
Chul Kim, MD, MPH | MedStar Health
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Stemline - Orserdu Electrasant - For patients with ER+/HER2- ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i
Adam Brufsky, MD | Magee-Womens Hospital/UPMC Hillman Comprehensive Breast Cancer Center
10:40 AM
Head and Neck Cancer
John Deeken, MD | Inova Schar Cancer Institute
11:10 AM
Sarcomas and Rare Cancers
Alice Chen, MD | DCTD/NCI National Institute of Health
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Lilly-Peer insights to help identify and manage candidates for treatment with a CDK4/6 inhibitor
Ruemu Birhiray , MD | Partner, Hematology Oncology of Indiana/American Oncology Network
12:40 PM
Early-Stage Breast Cancer
Jane Meisel, MD | Emory Winship Cancer Institute
1:10 PM
Metastatic Breast Cancer
Claudine Isaacs, MD | Georgetown University Medical Center
1:40 PM
Survivorship
Stacy Wentworth, MD | Duke University School of Medicine, Duke Cancer Institute
2:10 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program